More Medical News
Lilly drug reduces stent clot risks, study finds
3/29/2008

Patients who got Eli Lilly and Co's
anti-clotting drug prasugrel after a coronary stent conduct
had fewer stent-related clots than those on standard drug
therapy, an analysis released on cheap handgun found.

More: - Brought to my attention by

Share |
(Posted in Medical School)
Share and enjoy
  • Digg
  • del.icio.us
  • DZone
  • Netvouz
  • NewsVine
  • Reddit
  • Slashdot
  • StumbleUpon
  • Technorati
  • YahooMyWeb
Post Comment

Notify me of followup comments via e-mail.

Entry 1 of 14196
Last Page | Next Page